Oncology Practice Management Issues


August 2014, Vol 4, No 5

FDA Update

FDA News

Ofatumumab Approved for Chronic Lymphocytic Leukemia The US Food and Drug Administration approved ofatumumab (Arzerra Injection, GlaxoSmithKline) in combination with chlor­ambucil, for the treatment of previously untreated patients with chronic lymphocytic leukemia, for whom fludarabine-based therapy is considered inappropriate. The [ Read More ]

New Clinical Trials Under Way

Clinical Trials Tracker

The following clinical trials are currently recruiting participants with myelodysplastic syndrome (MDS) for inclusion. Each trial description includes the NLM Identifier to use as reference with Clinical­ Trials.gov. 1. Alemtuzumab in Patients with MDS The goal of this phase 2, [ Read More ]

FDA-Approved Medications for the Treatment of Leukemia

ICD Codes

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of leukemia. The following sections include: Associated ICD-9-CM codes used for the classification of leukemia Drugs that have been FDA [ Read More ]